Global Antiviral Drugs Market Size, Status and Forecast 2025

Publisher Name :
Date: 10-Jan-2018
No. of pages: 94
Inquire Before Buying

This report studies the global Antiviral Drugs market, analyzes and researches the Antiviral Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

- AbbVie

- Bristol-Myers Squibb Company

- Cipla

- F. Hoffmann-La Roche

- Gilead Sciences

- GlaxoSmithKline

- Johnson & Johnson

- Merck

- Mylan

- Teva Pharmaceutical Industries

Market segment by Regions/Countries, this report covers

- United States

- EU

- Japan

- China

- India

- Southeast Asia

Market segment by Type, the product can be split into

- Branded Drugs

- Generic Drugs

Market segment by Application, Antiviral Drugs can be split into

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Antiviral Drugs Market Size, Status and Forecast 2025

Table of Contents
Global Antiviral Drugs Market Size, Status and Forecast 2025
1 Industry Overview of Antiviral Drugs
1.1 Antiviral Drugs Market Overview
1.1.1 Antiviral Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Antiviral Drugs Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Antiviral Drugs Market by Type
1.3.1 Branded Drugs
1.3.2 Generic Drugs
1.4 Antiviral Drugs Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
2 Global Antiviral Drugs Competition Analysis by Players
2.1 Antiviral Drugs Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 AbbVie
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Antiviral Drugs Revenue (Million USD) (2013-2018)
3.1.5 Recent Developments
3.2 Bristol-Myers Squibb Company
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Antiviral Drugs Revenue (Million USD) (2013-2018)
3.2.5 Recent Developments
3.3 Cipla
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Antiviral Drugs Revenue (Million USD) (2013-2018)
3.3.5 Recent Developments
3.4 F. Hoffmann-La Roche
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Antiviral Drugs Revenue (Million USD) (2013-2018)
3.4.5 Recent Developments
3.5 Gilead Sciences
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Antiviral Drugs Revenue (Million USD) (2013-2018)
3.5.5 Recent Developments
3.6 GlaxoSmithKline
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Antiviral Drugs Revenue (Million USD) (2013-2018)
3.6.5 Recent Developments
3.7 Johnson & Johnson
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Antiviral Drugs Revenue (Million USD) (2013-2018)
3.7.5 Recent Developments
3.8 Merck
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Antiviral Drugs Revenue (Million USD) (2013-2018)
3.8.5 Recent Developments
3.9 Mylan
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Antiviral Drugs Revenue (Million USD) (2013-2018)
3.9.5 Recent Developments
3.10 Teva Pharmaceutical Industries
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Antiviral Drugs Revenue (Million USD) (2013-2018)
3.10.5 Recent Developments
4 Global Antiviral Drugs Market Size by Type and Application (2013-2018)
4.1 Global Antiviral Drugs Market Size by Type (2013-2018)
4.2 Global Antiviral Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Antiviral Drugs in Future
4.4 Top Consumer/End Users of Antiviral Drugs
5 United States Antiviral Drugs Development Status and Outlook
5.1 United States Antiviral Drugs Market Size (2013-2018)
5.2 United States Antiviral Drugs Market Size and Market Share by Players (2013-2018)
5.3 United States Antiviral Drugs Market Size by Application (2013-2018)
6 EU Antiviral Drugs Development Status and Outlook
6.1 EU Antiviral Drugs Market Size (2013-2018)
6.2 EU Antiviral Drugs Market Size and Market Share by Players (2013-2018)
6.3 EU Antiviral Drugs Market Size by Application (2013-2018)
7 Japan Antiviral Drugs Development Status and Outlook
7.1 Japan Antiviral Drugs Market Size (2013-2018)
7.2 Japan Antiviral Drugs Market Size and Market Share by Players (2013-2018)
7.3 Japan Antiviral Drugs Market Size by Application (2013-2018)
8 China Antiviral Drugs Development Status and Outlook
8.1 China Antiviral Drugs Market Size (2013-2018)
8.2 China Antiviral Drugs Market Size and Market Share by Players (2013-2018)
8.3 China Antiviral Drugs Market Size by Application (2013-2018)
9 India Antiviral Drugs Development Status and Outlook
9.1 India Antiviral Drugs Market Size (2013-2018)
9.2 India Antiviral Drugs Market Size and Market Share by Players (2013-2018)
9.3 India Antiviral Drugs Market Size by Application (2013-2018)
10 Southeast Asia Antiviral Drugs Development Status and Outlook
10.1 Southeast Asia Antiviral Drugs Market Size (2013-2018)
10.2 Southeast Asia Antiviral Drugs Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Antiviral Drugs Market Size by Application (2013-2018)
11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Antiviral Drugs Market Size (Value) by Regions (2018-2025)
11.1.1 United States Antiviral Drugs Revenue and Growth Rate (2018-2025)
11.1.2 EU Antiviral Drugs Revenue and Growth Rate (2018-2025)
11.1.3 Japan Antiviral Drugs Revenue and Growth Rate (2018-2025)
11.1.4 China Antiviral Drugs Revenue and Growth Rate (2018-2025)
11.1.5 India Antiviral Drugs Revenue and Growth Rate (2018-2025)
11.1.6 Southeast Asia Antiviral Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Antiviral Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Antiviral Drugs Market Size by Application (2018-2025)
12 Antiviral Drugs Market Dynamics
12.1 Antiviral Drugs Market Opportunities
12.2 Antiviral Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Antiviral Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Antiviral Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Global Antiviral Drugs Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Antiviral Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Antiviral Drugs Market Share by Regions (2013-2018)
Figure United States Antiviral Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Antiviral Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Antiviral Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Antiviral Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Antiviral Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Antiviral Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Antiviral Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Antiviral Drugs Revenue Market Share by Type in 2017
Figure Branded Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Generic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Antiviral Drugs Market Share by Application in 2017
Figure Antiviral Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2013-2018)
Figure Antiviral Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2013-2018)
Figure Antiviral Drugs Market Size (Million USD) and Growth Rate in Online Pharmacies (2013-2018)
Table Antiviral Drugs Market Size (Million USD) by Players (2013-2018)
Figure Antiviral Drugs Market Size Share by Players in 2013
Figure Antiviral Drugs Market Size Share by Players in 2017
Table AbbVie Basic Information List
Table Antiviral Drugs Business Revenue (Million USD) of AbbVie (2013-2018)
Figure AbbVie Antiviral Drugs Business Revenue Market Share (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Antiviral Drugs Business Revenue (Million USD) of Bristol-Myers Squibb Company (2013-2018)
Figure Bristol-Myers Squibb Company Antiviral Drugs Business Revenue Market Share (2013-2018)
Table Cipla Basic Information List
Table Antiviral Drugs Business Revenue (Million USD) of Cipla (2013-2018)
Figure Cipla Antiviral Drugs Business Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Basic Information List
Table Antiviral Drugs Business Revenue (Million USD) of F. Hoffmann-La Roche (2013-2018)
Figure F. Hoffmann-La Roche Antiviral Drugs Business Revenue Market Share (2013-2018)
Table Gilead Sciences Basic Information List
Table Antiviral Drugs Business Revenue (Million USD) of Gilead Sciences (2013-2018)
Figure Gilead Sciences Antiviral Drugs Business Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table Antiviral Drugs Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
Figure GlaxoSmithKline Antiviral Drugs Business Revenue Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Antiviral Drugs Business Revenue (Million USD) of Johnson & Johnson (2013-2018)
Figure Johnson & Johnson Antiviral Drugs Business Revenue Market Share (2013-2018)
Table Merck Basic Information List
Table Antiviral Drugs Business Revenue (Million USD) of Merck (2013-2018)
Figure Merck Antiviral Drugs Business Revenue Market Share (2013-2018)
Table Mylan Basic Information List
Table Antiviral Drugs Business Revenue (Million USD) of Mylan (2013-2018)
Figure Mylan Antiviral Drugs Business Revenue Market Share (2013-2018)
Table Teva Pharmaceutical Industries Basic Information List
Table Antiviral Drugs Business Revenue (Million USD) of Teva Pharmaceutical Industries (2013-2018)
Figure Teva Pharmaceutical Industries Antiviral Drugs Business Revenue Market Share (2013-2018)
Table Global Antiviral Drugs Market Size (Million USD) by Product (2013-2018)
Figure Global Antiviral Drugs Revenue Market Share (%) by Product (2013-2018)
Figure Global Antiviral Drugs Market Share by Product in 2017
Table Global Antiviral Drugs Market Size by Application (2013-2018)
Figure Global Antiviral Drugs Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Antiviral Drugs
Figure United States Antiviral Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Antiviral Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Antiviral Drugs Market Size Share by Players in 2013
Figure United States Antiviral Drugs Market Size Share by Players in 2017
Table United States Antiviral Drugs Market Size by Application (2013-2018)
Figure United States Antiviral Drugs Revenue Market Share (%) by Application (2013-2018)
Figure United States Antiviral Drugs Market Size Share by Application in 2017
Figure EU Antiviral Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Antiviral Drugs Market Size (Million USD) by Players (2013-2018)
Figure EU Antiviral Drugs Market Size Share by Players in 2013
Figure EU Antiviral Drugs Market Size Share by Players in 2017
Table EU Antiviral Drugs Market Size by Application (2013-2018)
Figure EU Antiviral Drugs Revenue Market Share (%) by Application (2013-2018)
Figure EU Antiviral Drugs Market Size Share by Application in 2017
Figure Japan Antiviral Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Antiviral Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Antiviral Drugs Market Size Share by Players in 2013
Figure Japan Antiviral Drugs Market Size Share by Players in 2017
Table Japan Antiviral Drugs Market Size by Application (2013-2018)
Figure Japan Antiviral Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Japan Antiviral Drugs Market Size Share by Application in 2017
Figure China Antiviral Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table China Antiviral Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Antiviral Drugs Market Size Share by Players in 2013
Figure China Antiviral Drugs Market Size Share by Players in 2017
Table China Antiviral Drugs Market Size by Application (2013-2018)
Figure China Antiviral Drugs Revenue Market Share (%) by Application (2013-2018)
Figure China Antiviral Drugs Market Size Share by Application in 2017
Figure India Antiviral Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table India Antiviral Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Antiviral Drugs Market Size Share by Players in 2013
Figure India Antiviral Drugs Market Size Share by Players in 2017
Table India Antiviral Drugs Market Size by Application (2013-2018)
Figure India Antiviral Drugs Revenue Market Share (%) by Application (2013-2018)
Figure India Antiviral Drugs Market Size Share by Application in 2017
Figure Southeast Asia Antiviral Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Antiviral Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Antiviral Drugs Market Size Share by Players in 2013
Figure Southeast Asia Antiviral Drugs Market Size Share by Players in 2017
Table Southeast Asia Antiviral Drugs Market Size by Application (2013-2018)
Figure Southeast Asia Antiviral Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Antiviral Drugs Market Size Share by Application in 2017
Figure Global Antiviral Drugs Market Size and Growth Rate (2018-2025)
Table Global Antiviral Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Antiviral Drugs Market Size Share (2018-2025)
Figure Global Antiviral Drugs Market Size Share by Regions in 2025
Figure United States Antiviral Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Antiviral Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Antiviral Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Antiviral Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Antiviral Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Antiviral Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Antiviral Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Antiviral Drugs Market Size Share by Type in 2018
Figure Global Antiviral Drugs Market Size Share by Type in 2025
Table Global Antiviral Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Antiviral Drugs Market Size (Million USD) by Application in 2018
Figure Global Antiviral Drugs Market Size (Million USD) by Application in 2025
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Melatonin Market 2017 Forecast to 2022
    Published: 22-Jan-2018        Price: US 4880 Onwards        Pages: 120
    Melatonin, also known as N-acetyl-5-methoxy tryptamine, is a hormone that is produced by the pineal gland in animals and regulates sleep and wakefulness. Melatonin is also produced in plants where it functions as a first line of defense against oxidative stress. Scope of the Report: This report focuses on the Melatonin in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on ma......
  • Global Anti-Aging Drugs Market Research Report 2018
    Published: 19-Jan-2018        Price: US 2900 Onwards        Pages: 112
    In this report, the global Anti-Aging Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Anti-Aging Drugs in these regions, from 2013 to 2025 (forecast), covering - North America - Europe - China - J......
  • United States Fosfomycin Trometamol Market Report 2017
    Published: 19-Jan-2018        Price: US 3800 Onwards        Pages: 96
    In this report, the United States Fosfomycin Trometamol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth ra......
  • Global Hydroxychloroquine Sulfate Market Research Report 2018
    Published: 19-Jan-2018        Price: US 2900 Onwards        Pages: 117
    In this report, the global Hydroxychloroquine Sulfate market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hydroxychloroquine Sulfate in these regions, from 2013 to 2025 (forecast), covering - North America - Europe......
  • Global Paracetamol Sales Market Report 2018
    Published: 18-Jan-2018        Price: US 4000 Onwards        Pages: 116
    In this report, the global Paracetamol market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Paracetamol for these regions, from 2013 to 2025 (forecast), covering - United States - China - Europe - Japan - Southeas......
  • Global Pneumonia Vaccine Sales Market Report 2018
    Published: 18-Jan-2018        Price: US 4000 Onwards        Pages: 107
    In this report, the global Pneumonia Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Pneumonia Vaccine for these regions, from 2013 to 2025 (forecast), covering - United States - China - Europe - Japan......
  • 2015-2023 World Phenylketonuria (PKU) Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 18-Jan-2018        Price: US 2800 Onwards        Pages: 131
    Summary Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight. This report includes market status and forecast of global and major regions, with in......
  • 2015-2023 World Hirudin Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 18-Jan-2018        Price: US 2800 Onwards        Pages: 116
    Summary Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as follo......
  • Global Moxifloxacin HCl Sales Market Report 2018
    Published: 17-Jan-2018        Price: US 4000 Onwards        Pages: 125
    In this report, the global Moxifloxacin HCl market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Moxifloxacin HCl for these regions, from 2013 to 2025 (forecast), covering - United States - China - Europe - Japan......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs